Journal
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
Volume 22, Issue 12, Pages 1693-1696Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jvir.2011.09.014
Keywords
-
Funding
- NCI NIH HHS [P30 CA006973] Funding Source: Medline
Ask authors/readers for more resources
This commentary is written in response to a recent Cochrane Collaboration review published in March 2011 (1). The authors of this commentary would like to express their concerns over the conclusions of the Cochrane review, which state, There is no firm evidence to support or refute transarterial chemoembolization (TACE) or transarterial embolization (TAE) for patients with unresectable hepatocellular carcinoma (HCC).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available